Luis Taxa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luis Taxa has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Sandro Casavilca-Zambrano
Department of Pathology, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru
8 shared publications - Ashley Wolfe
Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan
6 shared publications - Carlos Barrionuevo
37Departamento de Patología, Instituto Nacional de Enfermedades Neoplásicas, and Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru
6 shared publications - Carlos Murga-Zamalloa
Department of Pathology, University of Illinois Chicago, Chicago, USA
6 shared publications - Chenguang Wang
Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, USA
6 shared publications - Kedar V. Inamdar
Henry Ford Hospital
6 shared publications
Latest Publications
- Open Access
- 6 February 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Clinicopathological factors associated with sentinel lymph node positivity in breast cancer using indocyanine green: a retrospective study in Peru
Sentinel lymph node biopsy (SLNB) guided by indocyanine green is an innovative technique with a high detection rate in breast cancer; however, Latin Americ
- 6 February 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Open AccessClinicopathological factors associated with sentinel lymph node positivity in breast cancer using indocyanine green: a retrospective study in Peru
Sentinel lymph node biopsy (SLNB) guided by indocyanine green is an innovative technique with a high detection rate in breast cancer; however, Latin Americ
- Open Access
- 30 October 2025
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 86 (4) , 471-476
Carcinoma cortical suprarrenal pediátrico con sobreexpresión de p53
Adrenal cortical carcinoma is an extremely rare paediatric malignancy which usually presents with hormonal manifestations. The diagnosis is generally advanced, and the disease course is aggressive. Imaging plays a crucial role in diagnosis, preoperative planning, and staging. We present the case of a 7-year-old patient with a tumour that compromised the entire left renal parenchyma, with no evidence of adrenal tissue on computed tomography; the initial clinical diagnosis was Wilms tumour. However, the histopathological study reveals an adrenal cortical carcinoma with p53 overexpression; Unfortunately, the prognosis was ominous, and the patient passed away 15 months after surgery.
- 30 October 2025
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 86 (4) , 471-476
Open AccessCarcinoma cortical suprarrenal pediátrico con sobreexpresión de p53
Adrenal cortical carcinoma is an extremely rare paediatric malignancy which usually presents with hormonal manifestations. The diagnosis is generally advanced, and the disease course is aggressive. Imaging plays a crucial role in diagnosis, preoperative planning, and staging. We present the case of a 7-year-old patient with a tumour that compromised the entire left renal parenchyma, with no evidence of adrenal tissue on computed tomography; the initial clinical diagnosis was Wilms tumour. However, the histopathological study reveals an adrenal cortical carcinoma with p53 overexpression; Unfortunately, the prognosis was ominous, and the patient passed away 15 months after surgery.
- Open Access
- 12 April 2023
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 43 (2) , e1478
Hamartoma lipomatoso pancreático: Reporte de caso y revisión de la literatura
Los hamartomas pancreáticos (HP) son lesiones no neoplásicas extremadamente inusuales y representan < 1% de todos los hamartomas. Además, existe una variante distintiva denominada Hamartoma Lipomatoso Pancreático (HLP), que es aún más raro, con solo 5 casos, incluyendo el presente reporte, descritos en la literatura. HLP carecen de características específicas y clínicamente puede ser confundido con otras lesiones lipomatosas pancreáticas, como lipoma, lipomatosis pancreática, PEComa, liposarcoma y tumores malignos con componentes lipomatosos. El presente reporte describe un caso de HLP en un paciente varón de 70 años, que aquejaba de dolor y masa abdominal, preoperatoriamente diagnosticado como tumor neuroendocrino de bajo grado no funcionante pancreático. Subsecuentemente, fue sometido a enucleación lapar ógico postoperatorio y los estudios de inmunohistoquímica confirmaron el diagnóstico de HLP.
- 12 April 2023
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 43 (2) , e1478
Open AccessHamartoma lipomatoso pancreático: Reporte de caso y revisión de la literatura
Los hamartomas pancreáticos (HP) son lesiones no neoplásicas extremadamente inusuales y representan < 1% de todos los hamartomas. Además, existe una variante distintiva denominada Hamartoma Lipomatoso Pancreático (HLP), que es aún más raro, con solo 5 casos, incluyendo el presente reporte, descritos en la literatura. HLP carecen de características específicas y clínicamente puede ser confundido con otras lesiones lipomatosas pancreáticas, como lipoma, lipomatosis pancreática, PEComa, liposarcoma y tumores malignos con componentes lipomatosos. El presente reporte describe un caso de HLP en un paciente varón de 70 años, que aquejaba de dolor y masa abdominal, preoperatoriamente diagnosticado como tumor neuroendocrino de bajo grado no funcionante pancreático. Subsecuentemente, fue sometido a enucleación lapar ógico postoperatorio y los estudios de inmunohistoquímica confirmaron el diagnóstico de HLP.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Supplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Supplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis.Significance:This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis.Significance:This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis.Significance:This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis.Significance:This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Supplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
Supplementary Data from Notch Signaling Promotes Mature T-Cell Lymphomagenesis
- Open Access
- 4 November 2022
- Published by Springer Nature in Blood Cancer Journal
- Vol. 12 (11) , 1-13
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
Neoplasms originating from thymic T-cell progenitors and post-thymic mature T-cell subsets account for a minority of lymphoproliferative neoplasms. These T-cell derived neoplasms, while molecularly and genetically heterogeneous, exploit transcription factors and signaling pathways that are critically important in normal T-cell biology, including those implicated in antigen-, costimulatory-, and cytokine-receptor signaling. The transcription factor GATA-3 regulates the growth and proliferation of both immature and mature T cells and has recently been implicated in T-cell neoplasms, including the most common mature T-cell lymphoma observed in much of the Western world. Here we show that GATA-3 is a proto-oncogene across the spectrum of T-cell neoplasms, including those derived from T-cell progenitors and their mature progeny, and further define the transcriptional programs that are GATA-3 dependent, which include therapeutically targetable gene products. The discovery that p300-dependent acetylation regulates GATA-3 mediated transcription by attenuating DNA binding has novel therapeutic implications. As most patients afflicted with GATA-3 driven T-cell neoplasms will succumb to their disease within a few years of diagnosis, these findings suggest opportunities to improve outcomes for these patients.
- 4 November 2022
- Published by Springer Nature in Blood Cancer Journal
- Vol. 12 (11) , 1-13
Open AccessGATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
Neoplasms originating from thymic T-cell progenitors and post-thymic mature T-cell subsets account for a minority of lymphoproliferative neoplasms. These T-cell derived neoplasms, while molecularly and genetically heterogeneous, exploit transcription factors and signaling pathways that are critically important in normal T-cell biology, including those implicated in antigen-, costimulatory-, and cytokine-receptor signaling. The transcription factor GATA-3 regulates the growth and proliferation of both immature and mature T cells and has recently been implicated in T-cell neoplasms, including the most common mature T-cell lymphoma observed in much of the Western world. Here we show that GATA-3 is a proto-oncogene across the spectrum of T-cell neoplasms, including those derived from T-cell progenitors and their mature progeny, and further define the transcriptional programs that are GATA-3 dependent, which include therapeutically targetable gene products. The discovery that p300-dependent acetylation regulates GATA-3 mediated transcription by attenuating DNA binding has novel therapeutic implications. As most patients afflicted with GATA-3 driven T-cell neoplasms will succumb to their disease within a few years of diagnosis, these findings suggest opportunities to improve outcomes for these patients.
- 1 October 2022
- Published by Elsevier in Revista Española de Patología
- Vol. 55 (4) , 282-287
Carcinoma hepatocelular ectópico: reporte de caso y revisión de la literatura
- 1 October 2022
- Published by Elsevier in Revista Española de Patología
- Vol. 55 (4) , 282-287
Carcinoma hepatocelular ectópico: reporte de caso y revisión de la literatura
- Open Access
- 27 September 2022
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 22 (3) , e1510
Metástasis gástrica de tumor de células germinales mixto primario testicular: reporte de caso
Los tumores testiculares son raros; sin embargo, en la población masculina dentro del grupo etáreo de 15 a 29 años, el cáncer de testículo es el tumor sólido más común, siendo el tumor de células germinales del tipo no seminomatoso, el más frecuente. La metástasis linfática o hematógena puede darse en este tipo de tumores, siendo más frecuente que se dé a nivel pulmonar o hepático y muy infrecuente a nivel gástrico. Se presenta el caso de un paciente varón de 30 años que cursa con hemorragia digestiva alta y se realiza una gastroscopia donde se evidencia dos lesiones ulceradas en cuerpo gástrico cuyo informe de patología reporta neoplasia maligna indiferenciada de células pequeñas y redondas. Se realiza tomografía de cerebro, tórax y abdomino pélvica; donde se evidencia testículo derecho de apariencia tumoral con implante secundario en hemisferio cerebeloso izquierdo, múltiples implantes en parénquima pulmonar, en parénquima hepático, esplénico y adenopatías retroperitoneales. Asimismo, se realiza dosaje de B HCG 355354, AFP 500 y DHL 1669. Por lo tanto, se realiza orquiectomía radical derecha, con informe patológico que reporta tumor de células germinales de tipo mixto y se concluye como un tumor de células germinales primario de testículo derecho estadio clínico IIIC de alto riesgo por metástasis hepática, esplénica, pulmonar, gástrica y cerebral.
- 27 September 2022
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 22 (3) , e1510
Open AccessMetástasis gástrica de tumor de células germinales mixto primario testicular: reporte de caso
Los tumores testiculares son raros; sin embargo, en la población masculina dentro del grupo etáreo de 15 a 29 años, el cáncer de testículo es el tumor sólido más común, siendo el tumor de células germinales del tipo no seminomatoso, el más frecuente. La metástasis linfática o hematógena puede darse en este tipo de tumores, siendo más frecuente que se dé a nivel pulmonar o hepático y muy infrecuente a nivel gástrico. Se presenta el caso de un paciente varón de 30 años que cursa con hemorragia digestiva alta y se realiza una gastroscopia donde se evidencia dos lesiones ulceradas en cuerpo gástrico cuyo informe de patología reporta neoplasia maligna indiferenciada de células pequeñas y redondas. Se realiza tomografía de cerebro, tórax y abdomino pélvica; donde se evidencia testículo derecho de apariencia tumoral con implante secundario en hemisferio cerebeloso izquierdo, múltiples implantes en parénquima pulmonar, en parénquima hepático, esplénico y adenopatías retroperitoneales. Asimismo, se realiza dosaje de B HCG 355354, AFP 500 y DHL 1669. Por lo tanto, se realiza orquiectomía radical derecha, con informe patológico que reporta tumor de células germinales de tipo mixto y se concluye como un tumor de células germinales primario de testículo derecho estadio clínico IIIC de alto riesgo por metástasis hepática, esplénica, pulmonar, gástrica y cerebral.